| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ALKBH4 TPM2 TPM3 TPM4 GPHN EZR TPR MYH2 MYH3 ANK2 MYO9B IMPACT DNM1L DST FRG1 SYNE2 DNM3 MYH15 DNM1 UTRN FKBP4 EPB41L2 MX2 DNM2 | 3.39e-10 | 1099 | 97 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | ALKBH4 TPM2 TPM3 TPM4 EZR MYH2 MYH3 MYO9B IMPACT DST FRG1 SYNE2 MYH15 UTRN EPB41L2 | 1.03e-08 | 479 | 97 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | histone binding | SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 CHD5 TONSL SMARCA4 TSPY10 | 6.64e-08 | 265 | 97 | 11 | GO:0042393 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 HSP90B1 SMARCA5 CRACR2A MYO9B DNM1L MCM7 AK9 ARHGAP35 NUDT13 NUDT12 CHD5 DNM3 SMARCA4 DNM1 DNAH6 MX2 DNM2 | 1.02e-07 | 839 | 97 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 HSP90B1 SMARCA5 CRACR2A MYO9B DNM1L MCM7 AK9 ARHGAP35 NUDT13 NUDT12 CHD5 DNM3 SMARCA4 DNM1 DNAH6 MX2 DNM2 | 1.04e-07 | 840 | 97 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 HSP90B1 SMARCA5 CRACR2A MYO9B DNM1L MCM7 AK9 ARHGAP35 NUDT13 NUDT12 CHD5 DNM3 SMARCA4 DNM1 DNAH6 MX2 DNM2 | 1.04e-07 | 840 | 97 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 HSP90B1 SMARCA5 CRACR2A MYO9B DNM1L MCM7 AK9 ARHGAP35 CHD5 DNM3 SMARCA4 DNM1 DNAH6 MX2 DNM2 | 9.55e-07 | 775 | 97 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | actin filament binding | 1.62e-06 | 227 | 97 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 5.16e-06 | 24 | 97 | 4 | GO:0120283 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 8.72e-06 | 279 | 97 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.40e-05 | 38 | 97 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | NAD+ diphosphatase activity | 6.98e-05 | 3 | 97 | 2 | GO:0000210 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.02e-04 | 50 | 97 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.19e-04 | 20 | 97 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.28e-04 | 53 | 97 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | GTP binding | 1.36e-04 | 397 | 97 | 9 | GO:0005525 | |
| GeneOntologyMolecularFunction | NADH pyrophosphatase activity | 1.39e-04 | 4 | 97 | 2 | GO:0035529 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.60e-04 | 22 | 97 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD2 RGPD8 MYO9B RGPD1 DNM1L ARHGAP35 PLEKHG6 SBF1 ACAP3 RGPD5 | 1.78e-04 | 507 | 97 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD2 RGPD8 MYO9B RGPD1 DNM1L ARHGAP35 PLEKHG6 SBF1 ACAP3 RGPD5 | 1.78e-04 | 507 | 97 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH3 HSP90B1 SMARCA5 MYO9B MCM7 AK9 CHD5 SMARCA4 MYH15 DNAH6 | 1.93e-04 | 614 | 97 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.77e-04 | 118 | 97 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 2.86e-04 | 439 | 97 | 9 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 2.86e-04 | 439 | 97 | 9 | GO:0019001 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.96e-04 | 441 | 97 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 4.83e-04 | 7 | 97 | 2 | GO:0031749 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 7.06e-04 | 36 | 97 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | microtubule binding | 7.62e-04 | 308 | 97 | 7 | GO:0008017 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 7.66e-04 | 37 | 97 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | dinucleotide phosphatase activity | 8.22e-04 | 9 | 97 | 2 | GO:0004551 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 8.95e-04 | 39 | 97 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 CHD5 SMARCA4 TSPY10 | 9.13e-04 | 739 | 97 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | tubulin binding | 1.14e-03 | 428 | 97 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD2 RGPD8 MYO9B RGPD1 DNM1L ARHGAP35 PLEKHG6 MNAT1 ACAP3 RGPD5 | 1.32e-03 | 656 | 97 | 10 | GO:0008047 |
| GeneOntologyMolecularFunction | GTPase activity | 1.37e-03 | 341 | 97 | 7 | GO:0003924 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.43e-03 | 127 | 97 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.46e-03 | 749 | 97 | 10 | GO:0005509 | |
| GeneOntologyBiologicalProcess | gonadal mesoderm development | 1.46e-15 | 9 | 97 | 7 | GO:0007506 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 6.07e-09 | 122 | 97 | 9 | GO:0006334 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 2.30e-08 | 142 | 97 | 9 | GO:0034728 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ALKBH4 TPM2 TPM3 TPM4 EZR MYH2 MYH3 HSP90B1 ANK2 MYO9B PPFIA1 ARHGAP35 FAT1 SCN1B SYNE2 LRP1 EPB41L2 DNM2 | 2.19e-07 | 912 | 97 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 2.10e-06 | 20 | 97 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 2.67e-06 | 249 | 97 | 9 | GO:0065004 | |
| GeneOntologyBiologicalProcess | mRNA transport | 5.56e-06 | 145 | 97 | 7 | GO:0051028 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 8.30e-06 | 9 | 97 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | mesoderm development | 9.37e-06 | 157 | 97 | 7 | GO:0007498 | |
| GeneOntologyBiologicalProcess | nuclear transport | 1.16e-05 | 378 | 97 | 10 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 1.16e-05 | 378 | 97 | 10 | GO:0006913 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.18e-05 | 10 | 97 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 1.62e-05 | 11 | 97 | 3 | GO:0016185 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.90e-05 | 175 | 97 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.90e-05 | 175 | 97 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.12e-05 | 178 | 97 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.31e-05 | 249 | 97 | 8 | GO:0015931 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.79e-05 | 13 | 97 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 3.00e-05 | 38 | 97 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.53e-05 | 14 | 97 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | TPM4 EZR HSPG2 MYO9B IMPACT DNM1L ARHGAP35 FAT1 DST SCN1B LRP1 DNM3 SMARCA4 EPHA10 EPB41L2 CDH17 DNM2 | 3.81e-05 | 1194 | 97 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | sex differentiation | 4.23e-05 | 352 | 97 | 9 | GO:0007548 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | ALKBH4 TPR SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 CHD5 EHMT1 SMARCA4 TSPY10 | 4.32e-05 | 741 | 97 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 4.40e-05 | 15 | 97 | 3 | GO:0070142 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 6.48e-05 | 372 | 97 | 9 | GO:0060485 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle recycling | 6.54e-05 | 17 | 97 | 3 | GO:1903423 | |
| GeneOntologyBiologicalProcess | vesicle scission | 6.55e-05 | 3 | 97 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | gonad development | 7.12e-05 | 292 | 97 | 8 | GO:0008406 | |
| GeneOntologyBiologicalProcess | RNA localization | 7.46e-05 | 217 | 97 | 7 | GO:0006403 | |
| GeneOntologyBiologicalProcess | chromatin organization | ALKBH4 TPR SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 CHD5 TONSL EHMT1 SMARCA4 TSPY10 | 7.51e-05 | 896 | 97 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 7.82e-05 | 18 | 97 | 3 | GO:0033275 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 8.02e-05 | 297 | 97 | 8 | GO:0045137 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 8.10e-05 | 383 | 97 | 9 | GO:0048608 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.56e-05 | 153 | 97 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | reproductive system development | 8.94e-05 | 388 | 97 | 9 | GO:0061458 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | ALKBH4 TPM2 TPM3 TPM4 EZR MYH3 HSP90B1 PPFIA1 ARHGAP35 FAT1 LRP1 EPB41L2 DNM2 | 9.75e-05 | 803 | 97 | 13 | GO:0030036 |
| GeneOntologyBiologicalProcess | muscle contraction | 1.13e-04 | 400 | 97 | 9 | GO:0006936 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.21e-04 | 54 | 97 | 4 | GO:0018208 | |
| GeneOntologyBiologicalProcess | intracellular transport | EZR TPR RGPD2 HSP90B1 SP100 MAGOH CRACR2A RGPD8 RGPD1 DNM1L FAM53C EPG5 NUP205 DST SYNE2 LRP1 MX2 RGPD5 | 1.90e-04 | 1496 | 97 | 18 | GO:0046907 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ALKBH4 TPR SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 TSPY8 TSPY1 CHD5 TONSL EHMT1 SMARCA4 TSPY10 | 2.34e-04 | 999 | 97 | 14 | GO:0071824 |
| GeneOntologyBiologicalProcess | nuclear export | 2.41e-04 | 185 | 97 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 3.20e-04 | 195 | 97 | 6 | GO:0006606 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.35e-04 | 127 | 97 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | import into nucleus | 3.76e-04 | 201 | 97 | 6 | GO:0051170 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 4.53e-04 | 7 | 97 | 2 | GO:0006742 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | GPHN EZR TPR RGPD2 SP100 ANK2 RGPD8 RGPD1 DNM1L FAM53C CCDC47 CEP250 TONSL RGPD5 | 5.69e-04 | 1091 | 97 | 14 | GO:0033365 |
| GeneOntologyBiologicalProcess | actin filament organization | 6.61e-04 | 509 | 97 | 9 | GO:0007015 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 7.82e-04 | 231 | 97 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 8.98e-04 | 91 | 97 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | protein folding | 1.08e-03 | 246 | 97 | 6 | GO:0006457 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.10e-03 | 547 | 97 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 1.10e-03 | 96 | 97 | 4 | GO:0048488 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle recycling | 1.16e-03 | 44 | 97 | 3 | GO:1903421 | |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 1.16e-03 | 44 | 97 | 3 | GO:0006346 | |
| GeneOntologyBiologicalProcess | nuclear pore complex assembly | 1.17e-03 | 11 | 97 | 2 | GO:0051292 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | EZR RGPD2 HSP90B1 ANK2 RGPD8 MYO9B ANXA6 RGPD1 DNM1L EPG5 FAT1 DST SBF1 CEP250 LRP1 DNM3 FKBP4 BANK1 DNM2 | 4.83e-08 | 934 | 97 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TPR SNRNP27 RGPD2 SP100 SMARCA5 MAGOH GTF2A1L RGPD8 RGPD1 MCM7 NUP205 DNAJC17 FRG1 CHD5 SYNE2 TONSL SF3A3 SMARCA4 ZNF830 MNAT1 EPB41L2 MX2 RGPD5 | 5.64e-08 | 1377 | 97 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | myofibril | 5.68e-08 | 273 | 97 | 11 | GO:0030016 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM2 TPM3 TPM4 EZR MYH2 MYH3 ANK2 MYO9B DNM1L DST FRG1 SYNE2 DNM3 MYH15 DNM1 DNAH6 FKBP4 CEP170B MX2 DNM2 AHNAK2 | 8.20e-08 | 1179 | 97 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM2 TPM3 TPM4 EZR MYH2 MYH3 ANK2 MYO9B DNM1L DST FRG1 SYNE2 DNM3 MYH15 DNM1 DNAH6 FKBP4 CEP170B MX2 DNM2 AHNAK2 | 9.19e-08 | 1187 | 97 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.05e-07 | 290 | 97 | 11 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 2.44e-07 | 249 | 97 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | muscle thin filament tropomyosin | 3.86e-07 | 4 | 97 | 3 | GO:0005862 | |
| GeneOntologyCellularComponent | nuclear pore | 4.48e-07 | 101 | 97 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | focal adhesion | TPM4 EZR HSPG2 HSP90B1 PPFIA1 ANXA6 FAT1 DST SYNE2 LRP1 EPB41L2 DNM2 | 7.42e-07 | 431 | 97 | 12 | GO:0005925 |
| GeneOntologyCellularComponent | cell-substrate junction | TPM4 EZR HSPG2 HSP90B1 PPFIA1 ANXA6 FAT1 DST SYNE2 LRP1 EPB41L2 DNM2 | 9.90e-07 | 443 | 97 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.27e-06 | 18 | 97 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.99e-06 | 20 | 97 | 4 | GO:0042405 | |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM2 TPM3 TPM4 EZR FILIP1 MYH2 MYH3 MYO9B ARHGAP35 DST MYH15 EPB41L2 DNM2 | 2.59e-06 | 576 | 97 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 5.33e-06 | 8 | 97 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | anchoring junction | TPM4 EZR HSPG2 MYH2 HSP90B1 ANK2 PPFIA1 ANXA6 FAT1 DST SCN1B SYNE2 LRP1 EPB41L2 CDH17 DNM2 | 1.02e-05 | 976 | 97 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.14e-05 | 10 | 97 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | sarcolemma | 2.96e-05 | 190 | 97 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 3.13e-05 | 78 | 97 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | annulate lamellae | 3.40e-05 | 14 | 97 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | contractile ring | 3.40e-05 | 14 | 97 | 3 | GO:0070938 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM2 TPM3 TPM4 EZR MYO9B DNM1L DST DNM3 DNM1 DNAH6 FKBP4 CEP170B MX2 DNM2 | 6.75e-05 | 899 | 97 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.21e-04 | 21 | 97 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | myosin complex | 1.63e-04 | 59 | 97 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 2.07e-04 | 25 | 97 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 2.61e-04 | 27 | 97 | 3 | GO:0005865 | |
| GeneOntologyCellularComponent | filopodium | 2.72e-04 | 123 | 97 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | nuclear envelope | 2.74e-04 | 560 | 97 | 10 | GO:0005635 | |
| GeneOntologyCellularComponent | intercalated disc | 2.83e-04 | 68 | 97 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | myosin II complex | 2.92e-04 | 28 | 97 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | cell cortex | 3.34e-04 | 371 | 97 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 3.39e-04 | 129 | 97 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | myofilament | 4.36e-04 | 32 | 97 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | T-tubule | 5.01e-04 | 79 | 97 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 5.26e-04 | 80 | 97 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | cell division site | 5.26e-04 | 80 | 97 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | actin filament | 5.97e-04 | 146 | 97 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | Z disc | 6.95e-04 | 151 | 97 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | inclusion body | 8.20e-04 | 90 | 97 | 4 | GO:0016234 | |
| GeneOntologyCellularComponent | microtubule | 8.33e-04 | 533 | 97 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | podosome | 9.09e-04 | 41 | 97 | 3 | GO:0002102 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 9.65e-04 | 94 | 97 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | I band | 1.06e-03 | 166 | 97 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | MCM complex | 1.14e-03 | 11 | 97 | 2 | GO:0042555 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.21e-03 | 349 | 97 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | A band | 1.82e-03 | 52 | 97 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone membrane | 1.87e-03 | 14 | 97 | 2 | GO:0098835 | |
| GeneOntologyCellularComponent | uropod | 1.87e-03 | 14 | 97 | 2 | GO:0001931 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.88e-03 | 278 | 97 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | cell trailing edge | 2.15e-03 | 15 | 97 | 2 | GO:0031254 | |
| GeneOntologyCellularComponent | muscle myosin complex | 2.45e-03 | 16 | 97 | 2 | GO:0005859 | |
| GeneOntologyCellularComponent | cleavage furrow | 2.87e-03 | 61 | 97 | 3 | GO:0032154 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone | 3.11e-03 | 18 | 97 | 2 | GO:0098833 | |
| GeneOntologyCellularComponent | spliceosomal complex | 3.29e-03 | 215 | 97 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | chromatin | PDS5B BNC2 SMARCA5 TSPY4 TSPY3 TSPY2 TSPY9 MCM7 TSPY8 TSPY1 CHD5 TONSL EHMT1 SMARCA4 TSPY10 | 3.31e-03 | 1480 | 97 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 3.46e-03 | 19 | 97 | 2 | GO:0098871 | |
| GeneOntologyCellularComponent | filopodium membrane | 4.23e-03 | 21 | 97 | 2 | GO:0031527 | |
| GeneOntologyCellularComponent | costamere | 4.63e-03 | 22 | 97 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | growth cone | 5.71e-03 | 245 | 97 | 5 | GO:0030426 | |
| GeneOntologyCellularComponent | synaptic membrane | 5.74e-03 | 583 | 97 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | cell-cell junction | 6.22e-03 | 591 | 97 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 6.44e-03 | 26 | 97 | 2 | GO:0099571 | |
| GeneOntologyCellularComponent | site of polarized growth | 6.52e-03 | 253 | 97 | 5 | GO:0030427 | |
| HumanPheno | Congenital contracture | 2.18e-05 | 165 | 38 | 8 | HP:0002803 | |
| HumanPheno | Abnormal facial expression | 4.99e-05 | 185 | 38 | 8 | HP:0005346 | |
| HumanPheno | Abnormal shoulder morphology | 5.87e-05 | 246 | 38 | 9 | HP:0003043 | |
| HumanPheno | Spinal rigidity | 6.57e-05 | 59 | 38 | 5 | HP:0003306 | |
| HumanPheno | Centrally nucleated skeletal muscle fibers | 7.13e-05 | 60 | 38 | 5 | HP:0003687 | |
| HumanPheno | Scapular winging | 7.72e-05 | 99 | 38 | 6 | HP:0003691 | |
| HumanPheno | Abnormality of the shoulder girdle musculature | 9.37e-05 | 149 | 38 | 7 | HP:0001435 | |
| HumanPheno | Ophthalmoplegia | 1.05e-04 | 265 | 38 | 9 | HP:0000602 | |
| HumanPheno | Type 1 muscle fiber predominance | 1.13e-04 | 66 | 38 | 5 | HP:0003803 | |
| HumanPheno | Mask-like facies | 1.32e-04 | 109 | 38 | 6 | HP:0000298 | |
| HumanPheno | Myopathy | 1.38e-04 | 341 | 38 | 10 | HP:0003198 | |
| HumanPheno | Ophthalmoparesis | 1.71e-04 | 350 | 38 | 10 | HP:0000597 | |
| HumanPheno | Hyperlordosis | 1.81e-04 | 222 | 38 | 8 | HP:0003307 | |
| HumanPheno | Lordosis | 1.81e-04 | 222 | 38 | 8 | HP:0002939 | |
| HumanPheno | Limited hip movement | 2.50e-04 | 78 | 38 | 5 | HP:0008800 | |
| HumanPheno | Type 1 muscle fiber atrophy | 2.89e-04 | 18 | 38 | 3 | HP:0011807 | |
| HumanPheno | Abnormal scapula morphology | 3.16e-04 | 181 | 38 | 7 | HP:0000782 | |
| HumanPheno | EMG: myopathic abnormalities | 3.33e-04 | 129 | 38 | 6 | HP:0003458 | |
| HumanPheno | Abnormal muscle fiber-type distribution | 3.35e-04 | 83 | 38 | 5 | HP:0033684 | |
| HumanPheno | Muscle stiffness | 3.35e-04 | 83 | 38 | 5 | HP:0003552 | |
| HumanPheno | Prenatal movement abnormality | 3.65e-04 | 246 | 38 | 8 | HP:0001557 | |
| HumanPheno | Abnormality of skeletal muscles | TPM2 TPM3 HSPG2 MYH3 DNM1L AK9 SBF1 CCDC47 FRG1 SYNE2 EHMT1 SMARCA4 CAVIN1 DNM2 | 4.45e-04 | 727 | 38 | 14 | HP:0040290 |
| MousePheno | abnormal synapse morphology | 4.15e-06 | 224 | 78 | 9 | MP:0009538 | |
| MousePheno | embryonic lethality before implantation | 7.76e-06 | 242 | 78 | 9 | MP:0006204 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 1.69e-05 | 203 | 78 | 8 | MP:0011094 | |
| MousePheno | abnormal mitosis | 7.85e-05 | 128 | 78 | 6 | MP:0004046 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 8.88e-05 | 16 | 78 | 3 | MP:0003701 | |
| MousePheno | abnormal somatic nervous system morphology | GPHN HSPG2 ANK2 IMPG1 DNM1L ARHGAP35 EPG5 RLBP1 EHBP1L1 DST SBF1 SCN1B CEP250 SYNE2 UTRN DNM2 | 1.41e-04 | 1025 | 78 | 16 | MP:0002752 |
| MousePheno | abnormal neuromuscular synapse morphology | 1.86e-04 | 95 | 78 | 5 | MP:0001053 | |
| MousePheno | abnormal intracellular organelle morphology | PDS5B RGPD2 RGPD8 RGPD1 DNM1L EPG5 CEP55 DST CEP250 SYNE2 DNM2 | 2.11e-04 | 546 | 78 | 11 | MP:0014239 |
| MousePheno | abnormal somatic motor system morphology | 2.15e-04 | 98 | 78 | 5 | MP:0001051 | |
| Domain | Dynamin_central | 1.83e-11 | 6 | 95 | 5 | IPR000375 | |
| Domain | GED | 1.83e-11 | 6 | 95 | 5 | SM00302 | |
| Domain | GED | 1.83e-11 | 6 | 95 | 5 | PS51388 | |
| Domain | Dynamin_M | 1.83e-11 | 6 | 95 | 5 | PF01031 | |
| Domain | Dynamin_GTPase_CS | 1.83e-11 | 6 | 95 | 5 | IPR019762 | |
| Domain | GED_dom | 1.83e-11 | 6 | 95 | 5 | IPR020850 | |
| Domain | GED | 1.83e-11 | 6 | 95 | 5 | PF02212 | |
| Domain | GED | 1.83e-11 | 6 | 95 | 5 | IPR003130 | |
| Domain | G_DYNAMIN_1 | 6.38e-11 | 7 | 95 | 5 | PS00410 | |
| Domain | DYNc | 6.38e-11 | 7 | 95 | 5 | SM00053 | |
| Domain | G_DYNAMIN_dom | 5.91e-09 | 14 | 95 | 5 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 5.91e-09 | 14 | 95 | 5 | PS51718 | |
| Domain | Dynamin_GTPase | 8.83e-09 | 15 | 95 | 5 | IPR001401 | |
| Domain | Dynamin_N | 8.83e-09 | 15 | 95 | 5 | PF00350 | |
| Domain | Dynamin_SF | 8.83e-09 | 15 | 95 | 5 | IPR022812 | |
| Domain | Grip | 2.02e-07 | 11 | 95 | 4 | SM00755 | |
| Domain | GRIP | 2.02e-07 | 11 | 95 | 4 | PF01465 | |
| Domain | Ran_BP1 | 3.01e-07 | 12 | 95 | 4 | PF00638 | |
| Domain | GRIP_dom | 3.01e-07 | 12 | 95 | 4 | IPR000237 | |
| Domain | GRIP | 3.01e-07 | 12 | 95 | 4 | PS50913 | |
| Domain | RANBD1 | 3.01e-07 | 12 | 95 | 4 | PS50196 | |
| Domain | RanBD | 4.34e-07 | 13 | 95 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 4.34e-07 | 13 | 95 | 4 | IPR000156 | |
| Domain | TROPOMYOSIN | 5.08e-07 | 4 | 95 | 3 | PS00326 | |
| Domain | Tropomyosin | 5.08e-07 | 4 | 95 | 3 | IPR000533 | |
| Domain | Tropomyosin | 5.08e-07 | 4 | 95 | 3 | PF00261 | |
| Domain | P-loop_NTPase | MYH2 MYH3 SMARCA5 MYO9B DNM1L MCM7 AK9 ARHGAP35 HS6ST1 CHD5 DNM3 SMARCA4 MYH15 DNM1 DNAH6 MX2 DNM2 | 1.16e-06 | 848 | 95 | 17 | IPR027417 |
| Domain | NAP | 1.42e-06 | 17 | 95 | 4 | PF00956 | |
| Domain | NAP_family | 1.42e-06 | 17 | 95 | 4 | IPR002164 | |
| Domain | PH_dom-like | EZR RGPD2 RGPD8 RGPD1 PLEKHG6 SBF1 DNM3 DNM1 EPB41L2 ACAP3 DNM2 RGPD5 | 1.68e-06 | 426 | 95 | 12 | IPR011993 |
| Domain | GCC2_Rab_bind | 4.40e-06 | 7 | 95 | 3 | IPR032023 | |
| Domain | Rab_bind | 4.40e-06 | 7 | 95 | 3 | PF16704 | |
| Domain | - | EZR RGPD2 RGPD8 RGPD1 PLEKHG6 SBF1 DNM3 DNM1 EPB41L2 ACAP3 DNM2 | 4.76e-06 | 391 | 95 | 11 | 2.30.29.30 |
| Domain | - | 1.49e-05 | 10 | 95 | 3 | 1.10.220.60 | |
| Domain | zf-NADH-PPase | 2.56e-05 | 2 | 95 | 2 | PF09297 | |
| Domain | NUDIX-like | 2.56e-05 | 2 | 95 | 2 | PF09296 | |
| Domain | NADH_PPase-like_N | 2.56e-05 | 2 | 95 | 2 | IPR015375 | |
| Domain | Znr_NADH_PPase | 2.56e-05 | 2 | 95 | 2 | IPR015376 | |
| Domain | Myosin_head_motor_dom | 4.06e-05 | 38 | 95 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.06e-05 | 38 | 95 | 4 | PS51456 | |
| Domain | Myosin_head | 4.06e-05 | 38 | 95 | 4 | PF00063 | |
| Domain | MYSc | 4.06e-05 | 38 | 95 | 4 | SM00242 | |
| Domain | Myosin_N | 5.55e-05 | 15 | 95 | 3 | PF02736 | |
| Domain | Myosin_N | 5.55e-05 | 15 | 95 | 3 | IPR004009 | |
| Domain | Myosin_tail_1 | 9.84e-05 | 18 | 95 | 3 | PF01576 | |
| Domain | Myosin_tail | 9.84e-05 | 18 | 95 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.16e-04 | 19 | 95 | 3 | IPR027401 | |
| Domain | - | 1.16e-04 | 19 | 95 | 3 | 4.10.270.10 | |
| Domain | TPR-contain_dom | 1.17e-04 | 150 | 95 | 6 | IPR013026 | |
| Domain | TPR_REGION | 1.97e-04 | 165 | 95 | 6 | PS50293 | |
| Domain | TPR | 1.97e-04 | 165 | 95 | 6 | PS50005 | |
| Domain | Actinin_actin-bd_CS | 2.10e-04 | 23 | 95 | 3 | IPR001589 | |
| Domain | Spectrin | 2.10e-04 | 23 | 95 | 3 | PF00435 | |
| Domain | ACTININ_2 | 2.10e-04 | 23 | 95 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.10e-04 | 23 | 95 | 3 | PS00019 | |
| Domain | - | 2.74e-04 | 248 | 95 | 7 | 1.25.40.20 | |
| Domain | ANK_REPEAT | 3.09e-04 | 253 | 95 | 7 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 3.16e-04 | 254 | 95 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 3.16e-04 | 254 | 95 | 7 | PS50297 | |
| Domain | CH | 3.35e-04 | 65 | 95 | 4 | SM00033 | |
| Domain | Ankyrin_rpt | 3.81e-04 | 262 | 95 | 7 | IPR002110 | |
| Domain | - | SMARCA5 DNM1L MCM7 AK9 ARHGAP35 CHD5 DNM3 SMARCA4 DNM1 DNAH6 MX2 DNM2 | 3.95e-04 | 746 | 95 | 12 | 3.40.50.300 |
| Domain | Spectrin_repeat | 4.23e-04 | 29 | 95 | 3 | IPR002017 | |
| Domain | CH | 4.45e-04 | 70 | 95 | 4 | PF00307 | |
| Domain | - | 4.70e-04 | 71 | 95 | 4 | 1.10.418.10 | |
| Domain | TPR | 5.13e-04 | 129 | 95 | 5 | SM00028 | |
| Domain | CH | 5.23e-04 | 73 | 95 | 4 | PS50021 | |
| Domain | SNF2_N | 5.68e-04 | 32 | 95 | 3 | IPR000330 | |
| Domain | Spectrin/alpha-actinin | 5.68e-04 | 32 | 95 | 3 | IPR018159 | |
| Domain | SNF2_N | 5.68e-04 | 32 | 95 | 3 | PF00176 | |
| Domain | SPEC | 5.68e-04 | 32 | 95 | 3 | SM00150 | |
| Domain | CH-domain | 5.79e-04 | 75 | 95 | 4 | IPR001715 | |
| Domain | TPR_repeat | 5.89e-04 | 133 | 95 | 5 | IPR019734 | |
| Domain | Ank | 1.09e-03 | 228 | 95 | 6 | PF00023 | |
| Domain | TPR_1 | 1.15e-03 | 90 | 95 | 4 | PF00515 | |
| Domain | TPR_1 | 1.15e-03 | 90 | 95 | 4 | IPR001440 | |
| Domain | TPR-like_helical_dom | 1.22e-03 | 233 | 95 | 6 | IPR011990 | |
| Domain | IQ | 1.30e-03 | 93 | 95 | 4 | PS50096 | |
| Domain | NUDIX_hydrolase_CS | 1.63e-03 | 12 | 95 | 2 | IPR020084 | |
| Domain | Znf_C2H2_matrin | 1.63e-03 | 12 | 95 | 2 | IPR000690 | |
| Domain | ANK | 1.78e-03 | 251 | 95 | 6 | SM00248 | |
| Domain | SEA | 2.24e-03 | 14 | 95 | 2 | SM00200 | |
| Domain | PH | 2.96e-03 | 278 | 95 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 3.02e-03 | 279 | 95 | 6 | PS50003 | |
| Domain | PH_domain | 3.07e-03 | 280 | 95 | 6 | IPR001849 | |
| Domain | ZF_MATRIN | 3.71e-03 | 18 | 95 | 2 | PS50171 | |
| Domain | - | 4.12e-03 | 207 | 95 | 5 | 1.25.40.10 | |
| Domain | Ank_2 | 4.84e-03 | 215 | 95 | 5 | PF12796 | |
| Domain | Ez/rad/moesin-like | 5.05e-03 | 21 | 95 | 2 | IPR000798 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.85e-06 | 40 | 73 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.10e-06 | 41 | 73 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.37e-06 | 42 | 73 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.68e-06 | 43 | 73 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.20e-06 | 47 | 73 | 5 | MM14939 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 4.62e-06 | 84 | 73 | 6 | MM14929 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.18e-06 | 49 | 73 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 5.30e-06 | 86 | 73 | 6 | MM15413 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 5.73e-06 | 50 | 73 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 6.32e-06 | 51 | 73 | 5 | MM15151 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 7.85e-06 | 92 | 73 | 6 | MM14951 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 9.22e-06 | 55 | 73 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.20e-05 | 58 | 73 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.20e-05 | 58 | 73 | 5 | MM14736 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.24e-05 | 277 | 73 | 9 | MM15414 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.10e-05 | 65 | 73 | 5 | MM15147 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 3.07e-05 | 35 | 73 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 3.44e-05 | 36 | 73 | 4 | M18647 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EZR MAGOH ANK2 MYO9B ARHGAP35 SCN1B DNM3 SMARCA4 DNM1 UTRN EPHA10 DNM2 | 3.57e-05 | 575 | 73 | 12 | M29853 |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.70e-05 | 73 | 73 | 5 | MM14948 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.76e-05 | 121 | 73 | 6 | M872 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.84e-05 | 37 | 73 | 4 | MM15102 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 4.28e-05 | 38 | 73 | 4 | M39549 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 4.65e-05 | 14 | 73 | 3 | M10122 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 6.49e-05 | 82 | 73 | 5 | MM15394 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 7.01e-05 | 43 | 73 | 4 | M1429 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.03e-04 | 18 | 73 | 3 | MM1549 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.18e-04 | 49 | 73 | 4 | M891 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 1.38e-04 | 51 | 73 | 4 | M39457 | |
| Pathway | REACTOME_SUMOYLATION | 2.38e-04 | 169 | 73 | 6 | MM14919 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.07e-04 | 114 | 73 | 5 | MM15361 | |
| Pathway | KEGG_ENDOCYTOSIS | 3.44e-04 | 181 | 73 | 6 | M1519 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.96e-04 | 261 | 73 | 7 | MM15676 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.20e-04 | 68 | 73 | 4 | MM14968 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 4.69e-04 | 70 | 73 | 4 | M12294 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | TPM3 TPM4 FILIP1 RGPD2 RGPD8 MYO9B RGPD1 ARHGAP35 DST PLEKHG6 CAVIN1 | 4.77e-04 | 649 | 73 | 11 | MM15690 |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 4.96e-04 | 271 | 73 | 7 | MM15406 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 6.32e-04 | 203 | 73 | 6 | M5485 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 7.74e-04 | 35 | 73 | 3 | MM15114 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 9.12e-04 | 37 | 73 | 3 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 9.12e-04 | 37 | 73 | 3 | MM15610 | |
| Pathway | REACTOME_CELL_CYCLE | PDS5B TPR RGPD2 SMARCA5 RGPD8 RGPD1 MCM7 NUP205 CEP250 MNAT1 | 1.04e-03 | 603 | 73 | 10 | MM14635 |
| Pathway | REACTOME_METABOLISM_OF_RNA | TPR SNRNP27 RGPD2 MAGOH RGPD8 RGPD1 NUP205 SF3A3 ZNF830 MNAT1 | 1.16e-03 | 612 | 73 | 10 | MM15547 |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 1.41e-03 | 11 | 73 | 2 | MM14732 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 1.53e-03 | 96 | 73 | 4 | M16121 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 1.69e-03 | 12 | 73 | 2 | M15243 | |
| Pathway | PID_RHOA_REG_PATHWAY | 1.72e-03 | 46 | 73 | 3 | M68 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.90e-03 | 439 | 73 | 8 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.21e-03 | 450 | 73 | 8 | M27078 | |
| Pubmed | TPM2 TPM3 TPM4 EZR PDS5B RGPD2 MYH2 MYH3 HSP90B1 SP100 SMARCA5 ANK2 RGPD8 PPFIA1 RGPD1 ZNF318 NUP205 DST GTF3C1 CCDC47 CHD5 SYNE2 MYH15 DNAH6 RGPD5 | 1.66e-13 | 1442 | 98 | 25 | 35575683 | |
| Pubmed | GPHN EZR TPR RGPD2 ANK2 RGPD8 PPFIA1 RGPD1 DNM1L ZNF318 DST SBF1 SYNE2 LRP1 EHMT1 DNM3 SMARCA4 DNM1 CEP170B EPB41L2 DNM2 | 2.66e-13 | 963 | 98 | 21 | 28671696 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM2 TPM3 TPM4 EZR TPR HSP90B1 SP100 ANXA6 DNM1L MCM7 CEP250 SF3A3 DNM3 SMARCA4 DNAH6 UTRN FKBP4 EPB41L2 DNM2 | 2.58e-12 | 847 | 98 | 19 | 35235311 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TPM4 EZR PDS5B SNRNP27 HSP90B1 SMARCA5 MAGOH ANXA6 ARHGAP35 NUP205 EHBP1L1 DST GTF3C1 SBF1 FRG1 SF3A3 EHMT1 DNM3 SMARCA4 DNM1 | 2.09e-11 | 1082 | 98 | 20 | 38697112 |
| Pubmed | TPM3 TPM4 EZR TPR RGPD2 HSPG2 MYH2 HSP90B1 MAGOH RGPD8 MYO9B RGPD1 MCM7 ZNF318 DST UTRN FKBP4 RGPD5 | 2.38e-11 | 844 | 98 | 18 | 25963833 | |
| Pubmed | 5.34e-11 | 118 | 98 | 9 | 30979931 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPM3 EZR PDS5B TPR HSP90B1 SMARCA5 MYO9B ANXA6 MCM7 ZNF318 NUP205 DST GTF3C1 SYNE2 SF3A3 SMARCA4 UTRN FKBP4 EPB41L2 | 6.66e-11 | 1024 | 98 | 19 | 24711643 |
| Pubmed | TPM3 GPHN EZR TPR SMARCA5 ANXA6 MCM7 ARHGAP35 NUP205 PLEKHG6 CCDC47 DNM3 SMARCA4 CAVIN1 UTRN FKBP4 EPB41L2 DNM2 | 8.98e-11 | 916 | 98 | 18 | 32203420 | |
| Pubmed | PDS5B TPR SMARCA5 ANXA6 ZNF318 NUP205 DST GTF3C1 SBF1 SYNE2 SMARCA4 UTRN FKBP4 EPB41L2 DNM2 | 4.70e-10 | 653 | 98 | 15 | 22586326 | |
| Pubmed | 8.85e-10 | 6 | 98 | 4 | 27251629 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM3 TPM4 GPHN TPR HSP90B1 SMARCA5 ANK2 DNM1L ZNF318 ARHGAP35 DST SMARCA4 UTRN FKBP4 EPB41L2 DNM2 AHNAK2 | 1.01e-09 | 934 | 98 | 17 | 33916271 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM3 TPM4 EZR TPR HSP90B1 SP100 SMARCA5 MCM7 CEP55 NUP205 DST GTF3C1 FRG1 CHD5 SF3A3 SMARCA4 CAVIN1 FKBP4 EPB41L2 | 2.02e-09 | 1257 | 98 | 19 | 36526897 |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.06e-09 | 7 | 98 | 4 | 15710750 | |
| Pubmed | TPR SNRNP27 RGPD2 RGPD8 PPFIA1 RGPD1 MCM7 ZNF318 DST GTF3C1 LRP1 UTRN | 2.49e-09 | 418 | 98 | 12 | 34709266 | |
| Pubmed | 4.11e-09 | 8 | 98 | 4 | 24282027 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.36e-09 | 271 | 98 | 10 | 32433965 | |
| Pubmed | 8.66e-09 | 285 | 98 | 10 | 21423176 | ||
| Pubmed | GPHN EZR TPR SMARCA5 DNM1L ZNF318 ARHGAP35 DST SF3A3 SMARCA4 UTRN MNAT1 | 2.07e-08 | 506 | 98 | 12 | 30890647 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM2 TPM3 TPM4 GPHN EZR HSP90B1 SP100 PPFIA1 ANXA6 DNM1L MCM7 NUP205 DERA EHBP1L1 SF3A3 DNM1 FKBP4 EPB41L2 AHNAK2 | 2.13e-08 | 1455 | 98 | 19 | 22863883 |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 12383797 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 24273169 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 12511974 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 2.17e-08 | 3 | 98 | 3 | 28395327 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 12517701 | ||
| Pubmed | The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. | 2.17e-08 | 3 | 98 | 3 | 32573516 | |
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 2.17e-08 | 3 | 98 | 3 | 24046449 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 3865200 | ||
| Pubmed | 2.27e-08 | 234 | 98 | 9 | 36243803 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPM2 TPM4 EZR TPR RGPD2 MYH2 MYH3 HSP90B1 HLA-F RGPD1 MCM7 MX2 DNM2 | 3.59e-08 | 647 | 98 | 13 | 26618866 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPM3 PDS5B TPR HSP90B1 SMARCA5 MYO9B MCM7 NUP205 DST GTF3C1 SBF1 CCDC47 SF3A3 SMARCA4 CAVIN1 UTRN EPB41L2 AHNAK2 | 4.00e-08 | 1353 | 98 | 18 | 29467282 |
| Pubmed | Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. | 5.81e-08 | 14 | 98 | 4 | 20802490 | |
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 8.66e-08 | 4 | 98 | 3 | 21689597 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 22846998 | ||
| Pubmed | A systematic nomenclature for mammalian tropomyosin isoforms. | 8.66e-08 | 4 | 98 | 3 | 25369766 | |
| Pubmed | Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts. | 8.66e-08 | 4 | 98 | 3 | 16765662 | |
| Pubmed | 9.52e-08 | 131 | 98 | 7 | 34551306 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD2 SMARCA5 RGPD8 RGPD1 DNM1L DERA GTF3C1 SF3A3 SMARCA4 DNM2 | 1.00e-07 | 370 | 98 | 10 | 22922362 |
| Pubmed | 1.37e-07 | 17 | 98 | 4 | 37042948 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | GPHN EZR PDS5B TPR SNRNP27 RGPD2 RGPD8 RGPD1 CEP55 GTF3C1 SF3A3 EHMT1 SMARCA4 CAVIN1 CEP170B RGPD5 | 1.45e-07 | 1155 | 98 | 16 | 20360068 |
| Pubmed | 1.68e-07 | 86 | 98 | 6 | 37253089 | ||
| Pubmed | 1.83e-07 | 215 | 98 | 8 | 35973513 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 9722593 | ||
| Pubmed | 2.50e-07 | 224 | 98 | 8 | 32941674 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPM3 PDS5B TPR FILIP1 SMARCA5 ZNF318 ARHGAP35 FAM53C GTF3C1 SMARCA4 EPB41L2 CDH17 DNM2 | 2.81e-07 | 774 | 98 | 13 | 15302935 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.16e-07 | 231 | 98 | 8 | 16452087 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM3 TPM4 EZR TPR HSP90B1 SMARCA5 MCM7 ARHGAP35 DNAJC17 CCDC47 FRG1 SYNE2 SF3A3 SMARCA4 CAVIN1 EPB41L2 AHNAK2 | 4.21e-07 | 1415 | 98 | 17 | 28515276 |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 23640057 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 18602423 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 23792823 | ||
| Pubmed | 4.41e-07 | 332 | 98 | 9 | 37433992 | ||
| Pubmed | GPHN EZR TPR SMARCA5 MCM7 ZNF318 ARHGAP35 CEP55 GTF3C1 SMARCA4 RGPD5 | 4.46e-07 | 549 | 98 | 11 | 38280479 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPM3 EZR PDS5B TPR HSP90B1 SMARCA5 ANXA6 DNM1L MCM7 NUP205 GTF3C1 CCDC47 SF3A3 EHMT1 SMARCA4 FKBP4 EPB41L2 | 4.64e-07 | 1425 | 98 | 17 | 30948266 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ALKBH4 HSPG2 PCNX3 MYO9B ARHGAP35 C2CD2L FAT1 EHBP1L1 KLHL25 DST SBF1 CHD5 EHMT1 CEP170B AHNAK2 | 4.80e-07 | 1105 | 98 | 15 | 35748872 |
| Pubmed | TPM3 TPM4 GPHN HSP90B1 ANK2 PPFIA1 DNM1L ARHGAP35 DST SBF1 SMARCA4 DNM1 DNAH6 UTRN CEP170B EPB41L2 DNM2 | 4.92e-07 | 1431 | 98 | 17 | 37142655 | |
| Pubmed | TPM3 TDRKH SP100 SMARCA5 PPFIA1 ZNF318 FAM53C C2CD2L FAT1 CHD5 LRP1 EHMT1 SMARCA4 CAVIN1 CEP170B | 5.44e-07 | 1116 | 98 | 15 | 31753913 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 21205196 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 18949001 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 25187515 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 9037092 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 8603673 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 26632511 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 24403063 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 7.53e-07 | 7 | 98 | 3 | 11353387 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 30944974 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 38838144 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 7.53e-07 | 7 | 98 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 7.53e-07 | 7 | 98 | 3 | 17372272 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 38657106 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 15252009 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 12191015 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 22821000 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 20682751 | ||
| Pubmed | TPM3 TDRKH MAGOH PCNX3 PPFIA1 ZNF318 CEP55 C2CD2L DST SBF1 CCDC47 FRG1 EHMT1 UTRN MNAT1 CEP170B EPB41L2 | 9.16e-07 | 1497 | 98 | 17 | 31527615 | |
| Pubmed | EZR HSP90B1 CRACR2A MYO9B ANXA6 HLA-F DNM1L MCM7 CEP55 NUP205 EHBP1L1 GTF3C1 CCDC47 CHD5 SMARCA4 | 9.60e-07 | 1168 | 98 | 15 | 19946888 | |
| Pubmed | 9.90e-07 | 27 | 98 | 4 | 19723784 | ||
| Pubmed | TPM2 TPM3 HSPG2 HSP90B1 MYO9B DNM1L GTF3C1 CCDC47 SMARCA4 CEP170B DNM2 | 1.08e-06 | 601 | 98 | 11 | 33658012 | |
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 1.10e-06 | 118 | 98 | 6 | 37105989 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.20e-06 | 8 | 98 | 3 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.20e-06 | 8 | 98 | 3 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.20e-06 | 8 | 98 | 3 | 28745977 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.20e-06 | 8 | 98 | 3 | 21310149 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.26e-06 | 377 | 98 | 9 | 38117590 | |
| Pubmed | 1.48e-06 | 497 | 98 | 10 | 23414517 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 23170932 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.80e-06 | 9 | 98 | 3 | 18394993 | |
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 11553612 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 10601307 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 9733766 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 28100513 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 28877029 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 17887960 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.82e-06 | 394 | 98 | 9 | 27248496 | |
| Pubmed | 2.23e-06 | 209 | 98 | 7 | 36779422 | ||
| Pubmed | TPM3 TPM4 HSPG2 SMARCA5 MAGOH RGPD1 ZNF318 NUP205 FAT1 DST GTF3C1 CHD5 SYNE2 EHMT1 SMARCA4 FKBP4 | 2.39e-06 | 1429 | 98 | 16 | 35140242 | |
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 10398046 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.57e-06 | 10 | 98 | 3 | 8857542 | |
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 27160050 | ||
| Interaction | TSPY8 interactions | 1.05e-07 | 3 | 96 | 3 | int:TSPY8 | |
| Interaction | MECP2 interactions | TPM4 EZR PDS5B SNRNP27 HSP90B1 SP100 SMARCA5 MAGOH ANXA6 ARHGAP35 NUP205 EHBP1L1 DST GTF3C1 SBF1 FRG1 SF3A3 EHMT1 DNM3 SMARCA4 DNM1 EPB41L2 | 1.21e-07 | 1287 | 96 | 22 | int:MECP2 |
| Interaction | HSPB8 interactions | 1.34e-07 | 172 | 96 | 9 | int:HSPB8 | |
| Interaction | MCM2 interactions | TPM3 TPM4 EZR TPR RGPD2 HSPG2 MYH2 HSP90B1 MAGOH RGPD8 MYO9B RGPD1 MCM7 ZNF318 DST TONSL UTRN FKBP4 RGPD5 | 6.79e-07 | 1081 | 96 | 19 | int:MCM2 |
| Interaction | ACTR1A interactions | TPM2 TPM3 TPM4 HSP90B1 DNM1L MCM7 SF3A3 FKBP4 CEP170B AHNAK2 | 7.39e-07 | 274 | 96 | 10 | int:ACTR1A |
| Interaction | PRKAG2 interactions | 8.61e-07 | 68 | 96 | 6 | int:PRKAG2 | |
| Interaction | ACTC1 interactions | GPHN EZR TPR HSP90B1 SMARCA5 MAGOH DNM1L ZNF318 ARHGAP35 DST SYNE2 SF3A3 SMARCA4 UTRN MNAT1 | 9.60e-07 | 694 | 96 | 15 | int:ACTC1 |
| Interaction | TSKS interactions | 1.27e-06 | 40 | 96 | 5 | int:TSKS | |
| Interaction | ACTA1 interactions | TPM2 TPM3 MYO9B CEP55 EHBP1L1 DST SMARCA4 DNAH6 UTRN EPB41L2 DNM2 | 1.55e-06 | 371 | 96 | 11 | int:ACTA1 |
| Interaction | DYRK1A interactions | TPM2 TPM4 TPR TNFRSF25 PPFIA1 FAM53C CEP55 TONSL DNM3 CAVIN1 DNM1 UTRN AHNAK2 | 2.14e-06 | 552 | 96 | 13 | int:DYRK1A |
| Interaction | SIRT7 interactions | PDS5B TPR ANXA6 MCM7 ZNF318 NUP205 DST GTF3C1 SBF1 SYNE2 SMARCA4 UTRN FKBP4 EPB41L2 DNM2 | 2.27e-06 | 744 | 96 | 15 | int:SIRT7 |
| Interaction | CCDC8 interactions | TPR TDRKH HSP90B1 SMARCA5 MYO9B ANXA6 MCM7 ZNF318 NUP205 DST GTF3C1 CEP250 UTRN EPB41L2 | 2.66e-06 | 656 | 96 | 14 | int:CCDC8 |
| Interaction | RCN1 interactions | 3.05e-06 | 250 | 96 | 9 | int:RCN1 | |
| Interaction | RGPD4 interactions | 3.31e-06 | 22 | 96 | 4 | int:RGPD4 | |
| Interaction | NAA40 interactions | TPM3 TPM4 GPHN TPR HSP90B1 SMARCA5 ANK2 DNM1L ZNF318 ARHGAP35 DST SMARCA4 UTRN FKBP4 EPB41L2 DNM2 AHNAK2 | 3.33e-06 | 978 | 96 | 17 | int:NAA40 |
| Interaction | ACTN1 interactions | 5.24e-06 | 341 | 96 | 10 | int:ACTN1 | |
| Interaction | RGPD2 interactions | 7.80e-06 | 27 | 96 | 4 | int:RGPD2 | |
| Interaction | NUP43 interactions | PDS5B RGPD8 ZNF318 DST FRG1 CEP250 SYNE2 TONSL EHMT1 SMARCA4 CAVIN1 AHNAK2 RGPD5 | 8.25e-06 | 625 | 96 | 13 | int:NUP43 |
| Interaction | RANBP2 interactions | TPR RGPD2 SP100 SMARCA5 RGPD8 ANXA6 RGPD1 NUP205 EPB41L2 RGPD5 | 8.64e-06 | 361 | 96 | 10 | int:RANBP2 |
| Interaction | SIRT6 interactions | SMARCA5 RGPD8 MCM7 ZNF318 NUP205 FAT1 GTF3C1 SBF1 TONSL EHMT1 SMARCA4 MNAT1 RGPD5 | 8.68e-06 | 628 | 96 | 13 | int:SIRT6 |
| Interaction | KDM1A interactions | TPM3 TPR SNRNP27 SMARCA5 PPFIA1 MCM7 ZNF318 DST GTF3C1 GABPB2 SF3A3 LRP1 EHMT1 CAVIN1 UTRN FKBP4 | 8.88e-06 | 941 | 96 | 16 | int:KDM1A |
| Interaction | FOXC1 interactions | 1.34e-05 | 228 | 96 | 8 | int:FOXC1 | |
| Interaction | RICTOR interactions | TPM3 TPM4 EZR RGPD2 HSP90B1 SP100 RGPD8 RGPD1 NUP205 GTF3C1 UTRN EPB41L2 AHNAK2 RGPD5 | 1.40e-05 | 759 | 96 | 14 | int:RICTOR |
| Interaction | RHOD interactions | TPM4 PCNX3 PPFIA1 DNM1L ARHGAP35 NUP205 EHBP1L1 SBF1 CCDC47 SYNE2 CAVIN1 UTRN | 1.74e-05 | 572 | 96 | 12 | int:RHOD |
| Interaction | ACTN2 interactions | 1.77e-05 | 171 | 96 | 7 | int:ACTN2 | |
| Interaction | PLCH2 interactions | 2.23e-05 | 12 | 96 | 3 | int:PLCH2 | |
| Interaction | H3C1 interactions | PDS5B TPR SMARCA5 ANK2 MCM7 DNAJC17 GTF3C1 WDR87 FRG1 TONSL EHMT1 DNM3 SMARCA4 MYH15 ZNF830 | 2.24e-05 | 901 | 96 | 15 | int:H3C1 |
| Interaction | OBSL1 interactions | TPM3 EZR PDS5B TPR HSP90B1 SMARCA5 MCM7 NUP205 DST GTF3C1 SYNE2 SF3A3 SMARCA4 CAVIN1 UTRN | 2.27e-05 | 902 | 96 | 15 | int:OBSL1 |
| Interaction | RCOR1 interactions | TPM3 TPR SP100 SMARCA5 PPFIA1 ZNF318 DST EHMT1 SMARCA4 CAVIN1 UTRN | 2.32e-05 | 494 | 96 | 11 | int:RCOR1 |
| Interaction | PACSIN2 interactions | 2.94e-05 | 185 | 96 | 7 | int:PACSIN2 | |
| Interaction | PRNP interactions | TPM3 TPM4 GPHN EZR HSP90B1 ANK2 ANXA6 DNM1L ZNF318 ARHGAP35 FAT1 EHBP1L1 SBF1 CCDC47 DNM1 FKBP4 EPB41L2 | 3.02e-05 | 1158 | 96 | 17 | int:PRNP |
| Interaction | PFN1 interactions | GPHN TPR ANK2 MYO9B DNM1L ARHGAP35 CHD5 SYNE2 DNM1 DNM2 AHNAK2 | 3.05e-05 | 509 | 96 | 11 | int:PFN1 |
| Interaction | RRBP1 interactions | 3.64e-05 | 341 | 96 | 9 | int:RRBP1 | |
| Interaction | EED interactions | TPM3 TPM4 EZR PDS5B TPR HSPG2 HSP90B1 SMARCA5 MAGOH DNM1L MCM7 NUP205 GTF3C1 FRG1 SF3A3 EHMT1 SMARCA4 CEP170B DNM2 | 4.39e-05 | 1445 | 96 | 19 | int:EED |
| Interaction | CUL7 interactions | TPM3 TPM4 EZR TPR HSP90B1 SMARCA5 MAGOH MCM7 NUP205 CEP250 SYNE2 SF3A3 CAVIN1 FKBP4 | 4.57e-05 | 845 | 96 | 14 | int:CUL7 |
| Interaction | RND3 interactions | 4.85e-05 | 273 | 96 | 8 | int:RND3 | |
| Interaction | SNRNP40 interactions | SNRNP27 HSPG2 MAGOH MCM7 ZNF318 DNAJC17 TONSL SF3A3 SMARCA4 ZNF830 MNAT1 EPB41L2 | 4.96e-05 | 637 | 96 | 12 | int:SNRNP40 |
| Interaction | BIRC3 interactions | TPM3 EZR PDS5B TPR HSP90B1 SMARCA5 ANXA6 DNM1L MCM7 NUP205 GTF3C1 CCDC47 SF3A3 EHMT1 SMARCA4 USP35 FKBP4 EPB41L2 | 5.17e-05 | 1334 | 96 | 18 | int:BIRC3 |
| Interaction | CDC5L interactions | TPR SNRNP27 HSP90B1 SMARCA5 MAGOH PPFIA1 DNM1L DNAJC17 DST FRG1 SF3A3 SMARCA4 ZNF830 DNM2 | 5.19e-05 | 855 | 96 | 14 | int:CDC5L |
| Interaction | TOP3B interactions | ALKBH4 TPM4 HSPG2 TDRKH HSP90B1 PCNX3 MYO9B ARHGAP35 AXIN2 C2CD2L FAT1 EHBP1L1 KLHL25 DST SBF1 CHD5 EHMT1 CEP170B AHNAK2 | 5.54e-05 | 1470 | 96 | 19 | int:TOP3B |
| Interaction | CD274 interactions | 6.70e-05 | 369 | 96 | 9 | int:CD274 | |
| Interaction | RGPD3 interactions | 7.37e-05 | 47 | 96 | 4 | int:RGPD3 | |
| Interaction | NPIPB6 interactions | 8.12e-05 | 18 | 96 | 3 | int:NPIPB6 | |
| Interaction | KDR interactions | 8.22e-05 | 150 | 96 | 6 | int:KDR | |
| Interaction | RHOF interactions | TPM4 PDS5B MYO9B PPFIA1 CEP55 NUP205 FAT1 EHBP1L1 SBF1 CCDC47 CAVIN1 UTRN | 8.39e-05 | 673 | 96 | 12 | int:RHOF |
| Interaction | TNIK interactions | 8.55e-05 | 381 | 96 | 9 | int:TNIK | |
| Interaction | RGPD1 interactions | 8.69e-05 | 49 | 96 | 4 | int:RGPD1 | |
| Interaction | WDR76 interactions | 8.90e-05 | 383 | 96 | 9 | int:WDR76 | |
| Interaction | MEX3A interactions | 9.08e-05 | 384 | 96 | 9 | int:MEX3A | |
| Interaction | SCN2B interactions | 9.12e-05 | 95 | 96 | 5 | int:SCN2B | |
| Interaction | FER interactions | 9.41e-05 | 50 | 96 | 4 | int:FER | |
| Interaction | TMEM9 interactions | 1.04e-04 | 226 | 96 | 7 | int:TMEM9 | |
| Interaction | HMGB1 interactions | TPM2 TPM4 SP100 SMARCA5 ZNF318 LRP1 SMARCA4 CAVIN1 MNAT1 DNM2 | 1.07e-04 | 486 | 96 | 10 | int:HMGB1 |
| Interaction | SUMO2 interactions | TPM3 EZR TPR HSP90B1 SP100 DNM1L DST GTF3C1 EHMT1 SMARCA4 AHNAK2 | 1.16e-04 | 591 | 96 | 11 | int:SUMO2 |
| Interaction | ABTB2 interactions | 1.22e-04 | 101 | 96 | 5 | int:ABTB2 | |
| Interaction | ACTN4 interactions | 1.24e-04 | 400 | 96 | 9 | int:ACTN4 | |
| Interaction | KIF20A interactions | TPM2 TPM3 TPM4 PDS5B SMARCA5 ANK2 RGPD8 ZNF318 NUP205 SYNE2 SF3A3 SMARCA4 CAVIN1 UTRN AHNAK2 | 1.30e-04 | 1052 | 96 | 15 | int:KIF20A |
| Interaction | PEX14 interactions | 1.40e-04 | 237 | 96 | 7 | int:PEX14 | |
| Interaction | EFTUD2 interactions | TPM3 TPM4 EZR TPR HSP90B1 SMARCA5 MAGOH MCM7 ARHGAP35 DNAJC17 CCDC47 FRG1 SYNE2 SF3A3 SMARCA4 CAVIN1 EPB41L2 AHNAK2 | 1.48e-04 | 1449 | 96 | 18 | int:EFTUD2 |
| Interaction | SNAPIN interactions | 1.58e-04 | 169 | 96 | 6 | int:SNAPIN | |
| Interaction | RHOA interactions | EZR MYO9B PPFIA1 AK9 ARHGAP35 CEP55 NUP205 FAT1 PLEKHG6 SBF1 CCDC47 SYNE2 CAVIN1 UTRN MX2 DNM2 | 1.63e-04 | 1199 | 96 | 16 | int:RHOA |
| Interaction | RHOV interactions | 1.63e-04 | 243 | 96 | 7 | int:RHOV | |
| Interaction | RHOH interactions | 1.64e-04 | 512 | 96 | 10 | int:RHOH | |
| Interaction | RHOB interactions | PDS5B PCNX3 MYO9B PPFIA1 ARHGAP35 CEP55 NUP205 C2CD2L FAT1 SBF1 CAVIN1 UTRN EPB41L2 | 1.72e-04 | 840 | 96 | 13 | int:RHOB |
| Interaction | WWTR1 interactions | 1.85e-04 | 422 | 96 | 9 | int:WWTR1 | |
| Interaction | FBXW7 interactions | TPM2 TPM3 HSPG2 HSP90B1 MAGOH MYO9B DNM1L MCM7 GTF3C1 CCDC47 TONSL SF3A3 SMARCA4 FKBP4 CEP170B DNM2 | 1.89e-04 | 1215 | 96 | 16 | int:FBXW7 |
| Interaction | CFTR interactions | TPM2 TPM3 TPM4 EZR PDS5B TPR RGPD2 MYH2 MYH3 HSP90B1 HLA-F RGPD1 MCM7 CEP55 TONSL CAVIN1 MX2 DNM2 | 1.93e-04 | 1480 | 96 | 18 | int:CFTR |
| Interaction | MIA2 interactions | 2.07e-04 | 113 | 96 | 5 | int:MIA2 | |
| Interaction | H3-3B interactions | 2.15e-04 | 114 | 96 | 5 | int:H3-3B | |
| Interaction | TERF2 interactions | 2.21e-04 | 340 | 96 | 8 | int:TERF2 | |
| Interaction | HDAC1 interactions | EZR TPR MYH2 SMARCA5 PPFIA1 MCM7 ZNF318 DST CCDC47 CHD5 CEP250 SYNE2 EHMT1 SMARCA4 UTRN | 2.28e-04 | 1108 | 96 | 15 | int:HDAC1 |
| Interaction | PIM3 interactions | 2.32e-04 | 63 | 96 | 4 | int:PIM3 | |
| Interaction | PHF21A interactions | 2.34e-04 | 343 | 96 | 8 | int:PHF21A | |
| Interaction | APPL1 interactions | 2.36e-04 | 182 | 96 | 6 | int:APPL1 | |
| Interaction | GSK3B interactions | HSP90B1 PPFIA1 RGPD1 DNM1L ARHGAP35 AXIN2 NUP205 DST TONSL CAVIN1 UTRN FKBP4 CEP170B | 2.37e-04 | 868 | 96 | 13 | int:GSK3B |
| Interaction | GOLGA1 interactions | 2.43e-04 | 183 | 96 | 6 | int:GOLGA1 | |
| Interaction | SNX33 interactions | 2.47e-04 | 64 | 96 | 4 | int:SNX33 | |
| Interaction | RND2 interactions | 2.52e-04 | 440 | 96 | 9 | int:RND2 | |
| Interaction | KCTD13 interactions | TPM3 TPM4 GPHN HSP90B1 ANK2 PPFIA1 DNM1L ARHGAP35 DST SBF1 SMARCA4 DNM1 DNAH6 UTRN CEP170B EPB41L2 DNM2 | 2.89e-04 | 1394 | 96 | 17 | int:KCTD13 |
| Interaction | CTTN interactions | 2.97e-04 | 450 | 96 | 9 | int:CTTN | |
| Interaction | TERF2IP interactions | PDS5B TDRKH SP100 MCM7 ZNF318 GTF3C1 SF3A3 SMARCA4 ZNF830 MNAT1 | 2.99e-04 | 552 | 96 | 10 | int:TERF2IP |
| Interaction | HASPIN interactions | 3.06e-04 | 123 | 96 | 5 | int:HASPIN | |
| Interaction | BCAP31 interactions | TPM2 MYH2 MYH3 HSP90B1 C2CD2L CCDC47 SYNE2 SMARCA4 MYH15 CAVIN1 | 3.08e-04 | 554 | 96 | 10 | int:BCAP31 |
| Interaction | MECOM interactions | 3.12e-04 | 358 | 96 | 8 | int:MECOM | |
| Interaction | DNMBP interactions | 3.18e-04 | 124 | 96 | 5 | int:DNMBP | |
| Interaction | NUP62 interactions | 3.31e-04 | 273 | 96 | 7 | int:NUP62 | |
| Interaction | TSPY3 interactions | 3.33e-04 | 6 | 96 | 2 | int:TSPY3 | |
| Interaction | PLK2 interactions | 3.48e-04 | 70 | 96 | 4 | int:PLK2 | |
| Interaction | MOB3C interactions | 3.49e-04 | 364 | 96 | 8 | int:MOB3C | |
| Interaction | ZBTB46 interactions | 3.50e-04 | 29 | 96 | 3 | int:ZBTB46 | |
| Interaction | SP1 interactions | 3.56e-04 | 365 | 96 | 8 | int:SP1 | |
| Interaction | RAC2 interactions | PDS5B PPFIA1 ARHGAP35 NUP205 FAT1 DST SBF1 CCDC47 SYNE2 CAVIN1 UTRN | 3.61e-04 | 674 | 96 | 11 | int:RAC2 |
| Interaction | GSK3A interactions | 3.71e-04 | 464 | 96 | 9 | int:GSK3A | |
| Interaction | MCAM interactions | 3.95e-04 | 468 | 96 | 9 | int:MCAM | |
| Interaction | ZBTB7A interactions | 4.09e-04 | 131 | 96 | 5 | int:ZBTB7A | |
| Interaction | H2BC8 interactions | PDS5B SMARCA5 EPG5 DNAJC17 GTF3C1 CCDC47 FRG1 EHMT1 SMARCA4 MNAT1 | 4.19e-04 | 576 | 96 | 10 | int:H2BC8 |
| Interaction | ZBBX interactions | 4.27e-04 | 31 | 96 | 3 | int:ZBBX | |
| Interaction | RGPD8 interactions | 4.31e-04 | 74 | 96 | 4 | int:RGPD8 | |
| Interaction | ADAM10 interactions | 4.37e-04 | 286 | 96 | 7 | int:ADAM10 | |
| Interaction | BAP1 interactions | TPM3 TPM4 EZR TPR HSP90B1 MYO9B DNM1L MCM7 CEP55 FAT1 DST GTF3C1 SF3A3 FKBP4 EPB41L2 DNM2 | 4.54e-04 | 1314 | 96 | 16 | int:BAP1 |
| Cytoband | Yp11.2 | 1.43e-09 | 94 | 98 | 7 | Yp11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYp11 | 3.72e-08 | 150 | 98 | 7 | chrYp11 | |
| Cytoband | 2p11.2 | 3.58e-04 | 64 | 98 | 3 | 2p11.2 | |
| Cytoband | 4q35 | 4.65e-04 | 15 | 98 | 2 | 4q35 | |
| GeneFamily | Tropomyosins | 1.77e-07 | 4 | 65 | 3 | 777 | |
| GeneFamily | Myosin heavy chains | 1.96e-05 | 15 | 65 | 3 | 1098 | |
| GeneFamily | Ankyrin repeat domain containing | 2.54e-05 | 242 | 65 | 7 | 403 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.81e-05 | 115 | 65 | 5 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.60e-05 | 206 | 65 | 6 | 682 | |
| GeneFamily | Nudix hydrolase family | 3.34e-03 | 24 | 65 | 2 | 667 | |
| GeneFamily | Nucleoporins | 5.89e-03 | 32 | 65 | 2 | 1051 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN | 7.44e-06 | 196 | 95 | 7 | M4990 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 8.49e-06 | 200 | 95 | 7 | M78 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | EZR RGPD2 TNFRSF25 RGPD8 RGPD1 ZNF318 EPG5 EHMT1 BANK1 RGPD5 | 8.72e-06 | 474 | 95 | 10 | M40991 |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 1.82e-05 | 225 | 95 | 7 | MM496 | |
| Coexpression | JONES_OVARY_NK_CELL | 1.84e-05 | 89 | 95 | 5 | M48353 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN | 4.46e-05 | 176 | 95 | 6 | M8884 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_F | 4.79e-05 | 55 | 95 | 4 | M2043 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 6.38e-05 | 274 | 95 | 7 | M289 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 7.66e-05 | 194 | 95 | 6 | M1132 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_MAC_DN | 8.33e-05 | 197 | 95 | 6 | M5161 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 8.81e-05 | 199 | 95 | 6 | M4635 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 9.05e-05 | 200 | 95 | 6 | M7978 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_8H_BMDC_UP | 9.05e-05 | 200 | 95 | 6 | M3811 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 9.72e-05 | 126 | 95 | 5 | M39132 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.13e-04 | 519 | 95 | 9 | M3395 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING | 1.42e-04 | 418 | 95 | 8 | MM3752 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.59e-04 | 543 | 95 | 9 | MM997 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 1.59e-04 | 140 | 95 | 5 | M617 | |
| Coexpression | WELCSH_BRCA1_TARGETS_DN | 1.65e-04 | 141 | 95 | 5 | M2428 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.48e-08 | 200 | 98 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-07 | 178 | 98 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.83e-07 | 198 | 98 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.93e-07 | 199 | 98 | 7 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.03e-07 | 200 | 98 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.69e-06 | 99 | 98 | 5 | 4f0346fe85ba006d1ab28a61624568522ffe5cb4 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-06 | 182 | 98 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-06 | 183 | 98 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.22e-06 | 183 | 98 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 3.22e-06 | 183 | 98 | 6 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-06 | 183 | 98 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.54e-06 | 186 | 98 | 6 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | Entopeduncular-Endothelial|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.76e-06 | 188 | 98 | 6 | 94774652fd42bad5012356672ffac8b6d2c22d37 | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.88e-06 | 189 | 98 | 6 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 190 | 98 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-06 | 195 | 98 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 195 | 98 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 4.64e-06 | 195 | 98 | 6 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.78e-06 | 196 | 98 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 197 | 98 | 6 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.06e-06 | 198 | 98 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.21e-06 | 199 | 98 | 6 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.21e-06 | 199 | 98 | 6 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.21e-06 | 199 | 98 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.36e-06 | 200 | 98 | 6 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 5.36e-06 | 200 | 98 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 1.73e-05 | 145 | 98 | 5 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.78e-05 | 160 | 98 | 5 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.51e-05 | 168 | 98 | 5 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-05 | 172 | 98 | 5 | eee45759284baa3ed77da6a5fbcc4f8f6c553106 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 178 | 98 | 5 | c661246269ce26c4fc62e12f86c5f90a2dcfdce0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 178 | 98 | 5 | e5e5f5b4a27e120a1076b1cb250fa25d0c336956 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-05 | 186 | 98 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Thalamus-Endothelial|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.69e-05 | 186 | 98 | 5 | dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 5.84e-05 | 187 | 98 | 5 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 5.84e-05 | 187 | 98 | 5 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.84e-05 | 187 | 98 | 5 | 57ea69f777420f0671b131c97bcce71d77e29286 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 187 | 98 | 5 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 187 | 98 | 5 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 187 | 98 | 5 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 188 | 98 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 6.45e-05 | 191 | 98 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 191 | 98 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 191 | 98 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-05 | 193 | 98 | 5 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | 3'_v3-Lung-Mast|Lung / Manually curated celltypes from each tissue | 6.95e-05 | 194 | 98 | 5 | 5e6eb81ddc9d5e22c1297734689f476d5a05bff6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.95e-05 | 194 | 98 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 6.95e-05 | 194 | 98 | 5 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 6.95e-05 | 194 | 98 | 5 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | 3'_v3-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 6.95e-05 | 194 | 98 | 5 | 7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.95e-05 | 194 | 98 | 5 | ae5357e2a276473cde1fc8c43acaf9f69da35fd7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.95e-05 | 194 | 98 | 5 | 3a0b8b5d0354c43da57bb951cd8ba878363c3de5 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 7.12e-05 | 195 | 98 | 5 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.12e-05 | 195 | 98 | 5 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.12e-05 | 195 | 98 | 5 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.12e-05 | 195 | 98 | 5 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.12e-05 | 195 | 98 | 5 | ecaaa3d071e763c40d05d088fbf9e8ca06f78f47 | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.12e-05 | 195 | 98 | 5 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.12e-05 | 195 | 98 | 5 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.29e-05 | 196 | 98 | 5 | 9a420a4eb46cb554bec641726fea5398ff60f630 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.29e-05 | 196 | 98 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.29e-05 | 196 | 98 | 5 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 196 | 98 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.47e-05 | 197 | 98 | 5 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.47e-05 | 197 | 98 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 7.47e-05 | 197 | 98 | 5 | 434ae0231972acba12d06279908cf407e70511ac | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.47e-05 | 197 | 98 | 5 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.47e-05 | 197 | 98 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 7.47e-05 | 197 | 98 | 5 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 7.47e-05 | 197 | 98 | 5 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.65e-05 | 198 | 98 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-E_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.65e-05 | 198 | 98 | 5 | 498f11441c0a0982738537bcfcfc2877866b7400 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-05 | 198 | 98 | 5 | 5c96778cf5623c662c2259fe70f8665c14a161dd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 198 | 98 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.65e-05 | 198 | 98 | 5 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.83e-05 | 199 | 98 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 7.83e-05 | 199 | 98 | 5 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | (2)_Fibroblasts|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.83e-05 | 199 | 98 | 5 | 777423b413376b0d3fbd92ff51dd0133fb54d293 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 199 | 98 | 5 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.83e-05 | 199 | 98 | 5 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 199 | 98 | 5 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 7.83e-05 | 199 | 98 | 5 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.83e-05 | 199 | 98 | 5 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 7.83e-05 | 199 | 98 | 5 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.83e-05 | 199 | 98 | 5 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.02e-05 | 200 | 98 | 5 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 98 | 5 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 98 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | severe-NK|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.02e-05 | 200 | 98 | 5 | 64e8a6c36e0c654b7b2416c9f19b9058215222b1 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.02e-05 | 200 | 98 | 5 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.02e-05 | 200 | 98 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.02e-05 | 200 | 98 | 5 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| Drug | Go7874 | 1.26e-07 | 12 | 93 | 4 | CID005327863 | |
| Drug | purealin | 1.35e-07 | 58 | 93 | 6 | CID006419303 | |
| Drug | amphidinolide D | 6.56e-07 | 5 | 93 | 3 | CID006439238 | |
| Drug | eudistomin M | 6.56e-07 | 5 | 93 | 3 | CID000145927 | |
| Drug | library 2 | 9.65e-07 | 19 | 93 | 4 | CID005270634 | |
| Drug | didansylcystine | 1.31e-06 | 6 | 93 | 3 | CID000167721 | |
| Drug | Topanol Ca | 2.28e-06 | 7 | 93 | 3 | CID000092905 | |
| Drug | CP-31 | 5.44e-06 | 9 | 93 | 3 | CID000452624 | |
| Drug | methylselenic acid | TNFRSF25 HSP90B1 ANK2 PPFIA1 MCM7 GTF3C1 SMARCA4 UTRN FKBP4 EPB41L2 | 7.16e-06 | 412 | 93 | 10 | ctd:C008493 |
| Drug | IASL | 7.75e-06 | 10 | 93 | 3 | CID002724305 | |
| Drug | DHBT | 9.45e-06 | 119 | 93 | 6 | CID000001855 | |
| Drug | AC1L9JXQ | 9.75e-06 | 33 | 93 | 4 | CID000446658 | |
| Drug | uranyl acetate | 1.39e-05 | 36 | 93 | 4 | CID000010915 | |
| Drug | AC1NRD2N | 1.41e-05 | 12 | 93 | 3 | CID005289322 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.44e-05 | 193 | 93 | 7 | 3262_UP | |
| Drug | Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A | 1.65e-05 | 197 | 93 | 7 | 3319_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.65e-05 | 197 | 93 | 7 | 2544_DN | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.70e-05 | 198 | 93 | 7 | 2849_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.76e-05 | 199 | 93 | 7 | 3273_UP | |
| Drug | TMBr-3 | 1.83e-05 | 13 | 93 | 3 | CID000518955 | |
| Drug | AC1MP21W | 2.32e-05 | 14 | 93 | 3 | CID003378340 | |
| Drug | goniodomin A | 2.32e-05 | 14 | 93 | 3 | CID006440832 | |
| Drug | A-G-T-C | 2.90e-05 | 15 | 93 | 3 | CID003037868 | |
| Drug | conen | 2.90e-05 | 15 | 93 | 3 | CID000093117 | |
| Drug | 2gzl | 3.73e-05 | 46 | 93 | 4 | CID006102719 | |
| Drug | DABMI | 4.30e-05 | 17 | 93 | 3 | CID000137371 | |
| Drug | NpCaM | 4.42e-05 | 48 | 93 | 4 | CID000122259 | |
| Drug | benzophenone-4-iodoacetamide | 6.10e-05 | 19 | 93 | 3 | CID000131289 | |
| Drug | Asp-pro | 6.82e-05 | 104 | 93 | 5 | CID000170612 | |
| Drug | acrylodan | 8.14e-05 | 56 | 93 | 4 | CID000104901 | |
| Drug | thulium | 9.29e-05 | 111 | 93 | 5 | CID000023961 | |
| Drug | etorphine | 1.00e-04 | 59 | 93 | 4 | CID000026721 | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.09e-04 | 184 | 93 | 6 | 1344_DN | |
| Drug | 7-azatryptophan | 1.10e-04 | 23 | 93 | 3 | CID005354789 | |
| Drug | dansylaziridine | 1.10e-04 | 23 | 93 | 3 | CID000104008 | |
| Drug | 1,3-di-o-tolylguanidine | 1.14e-04 | 61 | 93 | 4 | CID000007333 | |
| Drug | TCNB | 1.29e-04 | 119 | 93 | 5 | CID000008330 | |
| Drug | trichostatin A; Up 200; 0.1uM; MCF7; HG-U133A | 1.30e-04 | 190 | 93 | 6 | 331_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HG-U133A | 1.42e-04 | 193 | 93 | 6 | 1961_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.42e-04 | 193 | 93 | 6 | 6209_UP | |
| Drug | AC1L1KMJ | 1.44e-04 | 476 | 93 | 9 | CID000030956 | |
| Drug | yohimbine; Up 200; 22.9uM; MCF7; HT_HG-U133A_EA | 1.46e-04 | 194 | 93 | 6 | 1119_UP | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.46e-04 | 194 | 93 | 6 | 4132_DN | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 3272_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 5091_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 3217_DN | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 4624_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 93 | 6 | 4747_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A | 1.54e-04 | 196 | 93 | 6 | 1912_UP | |
| Drug | 5-IAF | 1.55e-04 | 66 | 93 | 4 | CID000123822 | |
| Drug | Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 6772_UP | |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | 1.59e-04 | 197 | 93 | 6 | 371_DN | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 2282_DN | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; HL60; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 2342_DN | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.59e-04 | 197 | 93 | 6 | 6257_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.63e-04 | 198 | 93 | 6 | 6625_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.63e-04 | 198 | 93 | 6 | 5533_DN | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; PC3; HT_HG-U133A | 1.63e-04 | 198 | 93 | 6 | 4661_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.63e-04 | 198 | 93 | 6 | 6786_UP | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.63e-04 | 198 | 93 | 6 | 6040_DN | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 93 | 6 | 5464_DN | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 93 | 6 | 7306_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 93 | 6 | 4383_DN | |
| Drug | Ribavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 93 | 6 | 6521_UP | |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 93 | 6 | 5928_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.68e-04 | 199 | 93 | 6 | 3430_DN | |
| Drug | valdecoxib; Up 200; 10uM; PC3; HT_HG-U133A | 1.72e-04 | 200 | 93 | 6 | 6408_UP | |
| Drug | MIBK | 1.95e-04 | 70 | 93 | 4 | CID000007909 | |
| Drug | poly(propyleneimine) | 2.01e-04 | 28 | 93 | 3 | ctd:C443641 | |
| Drug | 02 U | 2.06e-04 | 71 | 93 | 4 | CID000000178 | |
| Drug | NSC 32050 | 2.23e-04 | 29 | 93 | 3 | CID000022780 | |
| Drug | o-nitrophenyl beta-D-fucopyranoside | 2.41e-04 | 74 | 93 | 4 | CID000004597 | |
| Drug | tocainide | 2.47e-04 | 30 | 93 | 3 | CID000038945 | |
| Drug | AC1NRBPQ | 2.49e-04 | 137 | 93 | 5 | CID005288569 | |
| Drug | isofagomine | 2.54e-04 | 75 | 93 | 4 | CID000447607 | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 4.04e-10 | 5 | 90 | 4 | DOID:0110197 (implicated_via_orthology) | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 4.04e-10 | 5 | 90 | 4 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 4.04e-10 | 5 | 90 | 4 | DOID:11252 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 5.67e-08 | 13 | 90 | 4 | DOID:0112202 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 3.24e-06 | 10 | 90 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 3.24e-06 | 10 | 90 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 3.24e-06 | 10 | 90 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 3.24e-06 | 10 | 90 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 3.24e-06 | 10 | 90 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 3.24e-06 | 10 | 90 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 3.24e-06 | 10 | 90 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 3.24e-06 | 10 | 90 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.74e-06 | 80 | 90 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 5.92e-06 | 12 | 90 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 5.92e-06 | 12 | 90 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 5.92e-06 | 12 | 90 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Myotubular Myopathy | 7.68e-06 | 13 | 90 | 3 | C3661489 | |
| Disease | Centronuclear myopathy | 7.68e-06 | 13 | 90 | 3 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 7.68e-06 | 13 | 90 | 3 | C0410203 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 7.68e-06 | 13 | 90 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | Congenital Structural Myopathy | 7.68e-06 | 13 | 90 | 3 | C0752282 | |
| Disease | Myopathy, Centronuclear, 1 | 7.68e-06 | 13 | 90 | 3 | C4551952 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 9.12e-06 | 43 | 90 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 9.75e-06 | 14 | 90 | 3 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 9.75e-06 | 14 | 90 | 3 | C0410207 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.22e-05 | 15 | 90 | 3 | C3645536 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.22e-05 | 15 | 90 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.42e-05 | 48 | 90 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Congenital Fiber Type Disproportion | 2.17e-05 | 18 | 90 | 3 | C0546264 | |
| Disease | facioscapulohumeral muscular dystrophy (implicated_via_orthology) | 2.75e-05 | 3 | 90 | 2 | DOID:11727 (implicated_via_orthology) | |
| Disease | Cap Myopathy | 2.75e-05 | 3 | 90 | 2 | C3710589 | |
| Disease | Multiple pterygium syndrome | 5.50e-05 | 4 | 90 | 2 | C0265261 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 6.73e-05 | 71 | 90 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 1.37e-04 | 6 | 90 | 2 | C0220662 | |
| Disease | Inflammatory Myofibroblastic Tumor | 1.37e-04 | 6 | 90 | 2 | C0334121 | |
| Disease | Digitotalar Dysmorphism | 1.37e-04 | 6 | 90 | 2 | C1852085 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 1.37e-04 | 6 | 90 | 2 | C1834523 | |
| Disease | Congenital myopathy with fiber type disproportion | 1.37e-04 | 6 | 90 | 2 | cv:C0546264 | |
| Disease | Nemaline Myopathy, Childhood Onset | 1.91e-04 | 7 | 90 | 2 | C0546125 | |
| Disease | palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement | 1.91e-04 | 7 | 90 | 2 | EFO_0800400 | |
| Disease | obsolete_red blood cell distribution width | SNRNP27 TNFRSF25 MYO9B RGPD1 MCM7 AK9 EPG5 DERA RLBP1 EHBP1L1 SYNE2 SF3A3 DNM2 | 2.20e-04 | 1347 | 90 | 13 | EFO_0005192 |
| Disease | Myopathies, Nemaline | 2.55e-04 | 8 | 90 | 2 | C0206157 | |
| Disease | Nemaline myopathy | 2.55e-04 | 8 | 90 | 2 | cv:C0206157 | |
| Disease | coronary artery disease | PDS5B TDRKH PCNX3 MYO9B PPFIA1 EPG5 EHBP1L1 SF3A3 LRP1 SMARCA4 CAVIN1 CDH17 | 2.72e-04 | 1194 | 90 | 12 | EFO_0001645 |
| Disease | Distal arthrogryposis | 3.27e-04 | 9 | 90 | 2 | cv:C0265213 | |
| Disease | sexual dimorphism measurement | FILIP1 MYO9B RGPD1 EHBP1L1 CEP250 SF3A3 DNM3 SMARCA4 MNAT1 BANK1 EPB41L2 | 5.42e-04 | 1106 | 90 | 11 | EFO_0021796 |
| Disease | Congenital myopathy (disorder) | 5.95e-04 | 12 | 90 | 2 | C0270960 | |
| Disease | alcohol and nicotine codependence | 7.02e-04 | 13 | 90 | 2 | EFO_0004776 | |
| Disease | body surface area | 7.87e-04 | 643 | 90 | 8 | EFO_0022196 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 1.21e-03 | 17 | 90 | 2 | C1839839 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 1.21e-03 | 17 | 90 | 2 | OBA_2045173 | |
| Disease | vital capacity | FILIP1 HSPG2 MYH2 BNC2 AK9 DST GABPB2 DNM3 UTRN FKBP4 EPB41L2 | 1.34e-03 | 1236 | 90 | 11 | EFO_0004312 |
| Disease | testosterone measurement | EZR MYH2 GTF2A1L ANK2 MYO9B ZNF318 SYNE2 DNM3 UTRN FKBP4 BANK1 | 1.71e-03 | 1275 | 90 | 11 | EFO_0004908 |
| Disease | Arthrogryposis | 1.86e-03 | 21 | 90 | 2 | C0003886 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.32e-03 | 301 | 90 | 5 | DOID:684 (is_marker_for) | |
| Disease | Brugada Syndrome (disorder) | 2.43e-03 | 24 | 90 | 2 | C1142166 | |
| Disease | hair colour measurement | 2.78e-03 | 615 | 90 | 7 | EFO_0007822 | |
| Disease | platelet measurement | 2.82e-03 | 315 | 90 | 5 | EFO_0005036 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILRDEVIGDTVEVEF | 216 | Q8NDB2 | |
| IEDFVTREEEAELVR | 76 | Q9NXW9 | |
| EEDSQLRRVIEGELV | 1246 | Q9HCE0 | |
| AVEVEEVIEESRAER | 206 | Q6NZI2 | |
| REEDGVEEVEREIIK | 1296 | Q8TDI0 | |
| EIRQEIENETERISG | 106 | O00429 | |
| QIESEEAEVDVRERE | 41 | Q6ZN30 | |
| LEQLEETTREGERRE | 101 | Q53EZ4 | |
| RATIDEVETDVVEIE | 16 | Q96P50 | |
| QQIREDEEREGSELT | 396 | Q9Y2T1 | |
| VDSRGILRSQSEEEE | 416 | Q9BSW2 | |
| ILRSQSEEEEEVFGI | 421 | Q9BSW2 | |
| TIETEAQDTEVEEAR | 571 | Q9Y4F5 | |
| LLQGTREEDDVVSED | 161 | P08133 | |
| ETEEEEVSTVNVRRR | 1426 | Q9NTI5 | |
| REFREVSEAVVDTLE | 106 | P98160 | |
| LEETTRERTDVIQGD | 1496 | Q99666 | |
| LEEITRERTDVIQGD | 1496 | O14715 | |
| DGEEQTQDTELVETR | 241 | P30511 | |
| ELIRESDDGTEELEV | 431 | Q9NQX3 | |
| SDDGTEELEVRILVQ | 436 | Q9NQX3 | |
| GIEVELNEIESRCEE | 686 | Q92621 | |
| TETETESRERAEELE | 3411 | Q01484 | |
| EETGVIETSDRLDRE | 1086 | Q14517 | |
| TREQEELEEALEVER | 141 | P51948 | |
| TTERETEFAVLEEQR | 221 | Q17R60 | |
| VEEAVREGVIDRDTA | 1796 | Q03001 | |
| AETIREEIDGLQEEL | 6201 | Q03001 | |
| EVRLEIEAETDRVTG | 96 | Q05193 | |
| IERIDLETGENREVV | 2076 | Q07954 | |
| DRVGRQELEIVIGDE | 81 | P61326 | |
| RVIITEDDEDETTVE | 56 | Q96A33 | |
| RVTEGTIREEQEYEE | 761 | O43491 | |
| EVRLEIEAETDRVTG | 96 | Q9UQ16 | |
| QREVEAITEGVEEDE | 1411 | Q9H6A9 | |
| IEELEEEIEAERASR | 1121 | Q9UKX2 | |
| SRELEEISERLEEAG | 1146 | Q9UKX2 | |
| LEARVRELEGEVESE | 1821 | Q9UKX2 | |
| ARDSGVREIEAEIAE | 731 | Q8N3D4 | |
| ENTEQRAEEIESRVG | 651 | Q13136 | |
| GQTRLLVVDQETDEE | 81 | Q15599 | |
| EEDEIRRDRVEPQSV | 456 | Q5JZY3 | |
| EVRQEIEAETDRVTG | 96 | P50570 | |
| FDISETRTEVEVEEL | 156 | Q9P2X3 | |
| ESVEETIRREVAEEV | 236 | Q86X67 | |
| TIRREVAEEVGLEVE | 241 | Q86X67 | |
| GVEVDEDTIRRIEEL | 326 | O60243 | |
| ETLESELEARGEERR | 26 | Q96CX6 | |
| AGELTREELRQIAEE | 316 | P33993 | |
| TTRVEDATEREEEGD | 96 | O95248 | |
| EIREELASQRIEGAE | 741 | Q3KR16 | |
| GSRTDDEVVQREEEA | 41 | P14625 | |
| RKREEDEETQLDIVG | 31 | Q14331 | |
| QERIESLEDEGNIVT | 741 | Q9C0G6 | |
| LISSDELETEDERVV | 196 | Q9H0H3 | |
| RERGEEQVELSTIEE | 226 | O14523 | |
| AEREEEVETLRGQIQ | 1431 | Q9BV73 | |
| EEVLGDLRAESREQE | 1886 | Q9BV73 | |
| EESRSTRTLEQEIER | 116 | Q9NVM6 | |
| TRTLEQEIERLREEG | 121 | Q9NVM6 | |
| EGIRDDRNEEKRITE | 506 | P15311 | |
| DLTEEEDGGIIRRIQ | 141 | Q02790 | |
| ELTGETDNIFVIERE | 61 | Q12864 | |
| EEIRLAVEDGATEID | 141 | Q9Y315 | |
| QVLSESEEEEEGAVR | 351 | Q9NYF3 | |
| VGELISDSEADVREE | 1156 | Q9H9B1 | |
| LEETTRERTDVIQGD | 1481 | P0DJD0 | |
| VDAVVVTEGELEERE | 411 | Q8TAK5 | |
| EDEEQETDAIERLRG | 1251 | Q5TCS8 | |
| GELERIIADLEEEQR | 3261 | P46939 | |
| QFRAVRTTEGEEETE | 6801 | Q8WXH0 | |
| DGIEEVEREITRGRS | 601 | Q7Z7B0 | |
| ETTRERTDVIQGDDV | 1491 | P0DJD1 | |
| EVQVTLEETEGALER | 1551 | Q9Y2K3 | |
| RQITEEDLEGKTEEE | 86 | Q8WVK2 | |
| AIEEGTLEEIEEEVR | 1391 | P51532 | |
| IEELEEEIEAERATR | 1116 | P11055 | |
| ETIEDAVRREVEEES | 361 | Q9BQG2 | |
| SREQLTEGEEIAQEI | 901 | Q9NRY4 | |
| GEEGLQRTRITEEQD | 556 | Q8IVF2 | |
| EVVAEEEGLVERREE | 81 | A0A494C1R9 | |
| VVAEEEGLVERREEA | 76 | P0CW01 | |
| VVAEEEGLVERREEA | 76 | A6NKD2 | |
| EVVAEEEGLVERREE | 81 | P0CV99 | |
| VVAEEEGLVERREEA | 76 | Q01534 | |
| LEGELERAEERAEVS | 136 | P67936 | |
| REERLTFVGEDDIEI | 41 | Q9Y2W6 | |
| IDVDTEDVGDERVLL | 86 | Q9Y2W6 | |
| QVDLSIRVTDDDIGE | 331 | Q9UNN4 | |
| IRVTDDDIGEIIQVD | 336 | Q9UNN4 | |
| ALRELGETREREEQE | 556 | P12270 | |
| ETETRLRELSVAEDE | 451 | Q96HA7 | |
| SSQEERIEREEEGKE | 671 | Q9P2H5 | |
| EVLQLEEDERFEGRV | 76 | Q07699 | |
| ESEEEEREERSGLQL | 156 | P23497 | |
| ELNEREETREEAVRE | 51 | P12271 | |
| LREAEIEAVEVEIGR | 356 | Q93038 | |
| VVAEEEGLVERREEA | 76 | P0CV98 | |
| VVAEEEGLVERREEA | 76 | P0CW00 | |
| TISEAIVAEEDEEGR | 286 | Q96NB3 | |
| IVAEEDEEGRLDRQI | 291 | Q96NB3 | |
| RTGEEREEEEEEQIS | 351 | Q12874 | |
| ESEITDEDIDGILER | 666 | O60264 | |
| EEIDLETGILESRRD | 76 | Q12789 | |
| ILEGELERSEERAEV | 171 | P07951 | |
| EEEVTLEEEVSREGE | 1541 | Q6ZQQ6 | |
| EEEEERSRSLSQELV | 326 | Q5VUA4 | |
| VIIEGDLERTEERAE | 171 | P06753 | |
| LVEGEEVVRENETRL | 436 | P20592 | |
| ESREDETLLVVETEA | 1196 | Q13459 |